Sanj K. Patel

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanj K. Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHAIRMAN & CEO, Director Class A Ordinary Share 110K $2.53M $23.00 Nov 6, 2024 Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Kiniksa Pharmaceuticals, Ltd. CHAIRMAN & CEO, Director Class A Common Share 110K $1.97M $17.90 Apr 4, 2024 Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Kiniksa Pharmaceuticals International, plc CHAIRMAN & CEO, Director Class A Ordinary Share 79.6K $1.83M $23.00 Nov 6, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHAIRMAN & CEO, Director Class A Common Share 63K $1.13M $17.90 Apr 8, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHAIRMAN & CEO, Director Performance Share Unit 20K $358K $17.90 Apr 4, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHAIRMAN & CEO, Director Restricted Share Unit 34.4K Apr 8, 2024 Direct
Kiniksa Pharmaceuticals International, plc CHAIRMAN & CEO, Director Share Option 10K Nov 6, 2024 Direct
Kiniksa Pharmaceuticals International, plc CHAIRMAN & CEO, Director Restricted Share Unit 6.57K Sep 2, 2024 Direct

Insider Reports Filed by Sanj K. Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Nov 6, 2024 3 -$1.92M 4 Nov 8, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals International, plc Sep 1, 2024 9 -$298K 4 Sep 4, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals International, plc Jul 23, 2024 5 -$3.28M 4 Jul 25, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 6 -$72.9K 4 Apr 8, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$37.5K 4 Apr 3, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 7, 2024 1 -$1.37M 4 Mar 11, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 4, 2024 3 -$391K 4 Mar 6, 2024 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2023 8 -$118K 4 Sep 6, 2023 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$31.4K 4 Apr 11, 2023 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 16, 2023 6 -$61.3K 4 Mar 20, 2023 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 5 -$22.1K 4 Sep 6, 2022 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$59.8K 4 Mar 23, 2022 CHAIRMAN & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 16, 2022 3 -$19.5K 4 Mar 18, 2022 Chairman & CEO, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 Chairman & CEO, Director